The inhibition of acetylcholinesterase (AChE) is a cornerstone strategy for treating types of dementia such as Alzheimer’s disease (AD), where there is a progressive loss of acetylcholine (ACh) in the brain [153]. The gene discussed is ACHE; the disease is early-onset autosomal dominant Alzheimer disease.